Barclays Maintains Ambev at Equal-Weight, Cuts Price Target to $3
Barclays maintained its Equal-Weight rating on Ambev and lowered its price target to $3 from $3.50.
Barclays maintained its Equal-Weight rating on Ambev and lowered its price target to $3 from $3.50.